|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Concert Pharmaceuticals, Inc. (CNCE) |
|
|
$8.37 0.00 (0.00%) as of 4:30 Fri 3/3
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
47,940,000 |
Market
Cap: |
401.26(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$8.37 - $8.37 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Concert Pharmaceuticals is a late-stage clinical biopharmaceutical company that is developing CTP-543, a Janus Kinase 1 and Janus Kinase 2 inhibitor that Co. discovered through the application of its DCE Platform® (deuterated chemical entity platform). Co. is evaluating CTP-543 in a Phase 3 clinical program for the treatment of alopecia areata, a serious autoimmune dermatological condition. In addition to its wholly-owned development programs, Co. has entered into collaborative arrangements with companies to develop deuterium-modified versions of their marketed products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
227,052 |
Total Buy Value |
$0 |
$0 |
$0 |
$1,078,498 |
Total People Bought |
0 |
0 |
0 |
3 |
Total Buy Transactions |
0 |
0 |
0 |
3 |
Total Shares Sold |
0 |
0 |
0 |
81,977 |
Total Sell Value |
$0 |
$0 |
$0 |
$653,253 |
Total People Sold |
0 |
0 |
0 |
6 |
Total Sell Transactions |
0 |
0 |
0 |
14 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Stuart Nancy |
Chief Operating Officer |
|
2018-03-31 |
4/A |
D |
$22.90 |
$101,172 |
D/D |
(4,418) |
121,376 |
|
- |
|
Herscha Lynette |
General Counsel |
|
2018-03-31 |
4/A |
D |
$22.90 |
$84,318 |
D/D |
(3,682) |
33,818 |
|
- |
|
Tung Roger D |
Chief Executive Officer |
|
2018-03-31 |
4/A |
D |
$22.90 |
$134,881 |
D/D |
(5,890) |
598,923 |
|
- |
|
Cassella James V |
Chief Development Officer |
|
2018-03-31 |
4/A |
D |
$22.90 |
$101,172 |
D/D |
(4,418) |
40,582 |
|
- |
|
Lynch Ryan |
PAO |
|
2018-03-31 |
4 |
D |
$22.90 |
$22,007 |
D/D |
(961) |
5,039 |
|
- |
|
Cassella James V |
Chief Development Officer |
|
2018-03-31 |
4 |
D |
$22.90 |
$101,172 |
D/D |
(4,418) |
55,582 |
|
- |
|
Herscha Lynette |
General Counsel |
|
2018-03-31 |
4 |
D |
$22.90 |
$84,318 |
D/D |
(3,682) |
46,318 |
|
- |
|
Stuart Nancy |
Chief Operating Officer |
|
2018-03-31 |
4 |
D |
$22.90 |
$101,172 |
D/D |
(4,418) |
136,376 |
|
- |
|
Tung Roger D |
Chief Executive Officer |
|
2018-03-31 |
4 |
D |
$22.90 |
$134,881 |
D/D |
(5,890) |
638,923 |
|
- |
|
Tung Roger D |
Chief Executive Officer |
|
2018-03-02 |
4 |
D |
$21.04 |
$127,124 |
D/D |
(6,042) |
644,813 |
|
- |
|
Tung Roger D |
Chief Executive Officer |
|
2018-03-02 |
4 |
OE |
$4.58 |
$127,127 |
D/D |
27,757 |
650,855 |
|
- |
|
Aldrich Richard |
Director |
|
2018-02-01 |
4 |
AS |
$19.99 |
$38,901 |
I/I |
(1,946) |
0 |
|
- |
|
Aldrich Richard |
Director |
|
2018-01-31 |
4 |
AS |
$20.78 |
$104,053 |
I/I |
(5,000) |
1,946 |
|
- |
|
Aldrich Richard |
Director |
|
2018-01-30 |
4 |
AS |
$21.33 |
$106,650 |
I/I |
(5,000) |
6,946 |
|
- |
|
Aldrich Richard |
Director |
|
2018-01-29 |
4 |
AS |
$21.36 |
$106,800 |
I/I |
(5,000) |
11,946 |
|
- |
|
Aldrich Richard |
Director |
|
2018-01-26 |
4 |
AS |
$20.46 |
$102,300 |
I/I |
(5,000) |
16,946 |
|
- |
|
Aldrich Richard |
Director |
|
2018-01-25 |
4 |
AS |
$20.22 |
$163,302 |
I/I |
(8,054) |
44,351 |
|
- |
|
Stuart Nancy |
Chief Operating Officer |
|
2018-01-25 |
4 |
D |
$20.23 |
$223,865 |
D/D |
(11,066) |
140,794 |
|
- |
|
Stuart Nancy |
Chief Operating Officer |
|
2018-01-25 |
4 |
OE |
$4.58 |
$223,880 |
D/D |
48,882 |
151,860 |
|
- |
|
Aldrich Richard |
Director |
|
2018-01-24 |
4 |
AS |
$19.83 |
$198,300 |
I/I |
(10,000) |
47,405 |
|
- |
|
Aldrich Richard |
Director |
|
2018-01-23 |
4 |
AS |
$19.67 |
$196,750 |
I/I |
(10,000) |
52,405 |
|
- |
|
Aldrich Richard |
Director |
|
2018-01-22 |
4 |
AS |
$19.54 |
$195,450 |
I/I |
(10,000) |
57,405 |
|
- |
|
Aldrich Richard |
Director |
|
2018-01-19 |
4 |
AS |
$19.65 |
$196,550 |
I/I |
(10,000) |
62,405 |
|
- |
|
Aldrich Richard |
Director |
|
2018-01-18 |
4 |
AS |
$19.36 |
$193,950 |
I/I |
(10,000) |
67,405 |
|
- |
|
Aldrich Richard |
Director |
|
2018-01-17 |
4 |
AS |
$18.95 |
$189,900 |
I/I |
(10,000) |
72,405 |
|
- |
|
279 Records found
|
|
Page 6 of 12 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|